Drrx stock forecast.

DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.3 analysts have issued 12-month price objectives for Broadwind's stock. Their BWEN share price targets range from $6.00 to $9.00. On average, they predict the company's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 250.1% from the stock's current price. View analysts price targets for BWEN or …Nov 16, 2023 · Predictions of DRRX stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks. Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors can find some trueLatest Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced

View DURECT Corporation DRRX investment & stock information. Get the latest DURECT Corporation DRRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.The average one-year price target for DRRX / Durect Corp is $6.885. The forecasts range from a low of $5.05 to a high of $8.925. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or ...

DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...

Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ...Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00.

Nov 13, 2023 · Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ...

Let’s speak about penny stocks. These are equities that commerce for lower than $5 per share, on the very backside of the value vary. Whereas they’re priced that low for a purpose – and the explanations might fluctuate – a low value in itself doesn’t imply that the inventory’s fundamentals are bitter. Sensible buyers can …

Dec 1, 2023 · Read Full Company Summary for DRRX here. View DURECT Corporation DRRX investment & stock information. Get the latest DURECT Corporation DRRX detailed stock quotes, stock data, Real-Time ECN ... The average one-year price target for DRRX / Durect Corp is $6.885. The forecasts range from a low of $5.05 to a high of $8.925. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or ...Zacks Equity Research. Durect (DRRX) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $0.50 per share a year ago ...DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.Nov 29, 2023 · 3 analysts have issued 12-month price objectives for Broadwind's stock. Their BWEN share price targets range from $6.00 to $9.00. On average, they predict the company's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 250.1% from the stock's current price. View analysts price targets for BWEN or view top ...

DURECT Announces 1-for-10 Reverse Stock Split. CUPERTINO, Calif., Nov. 28, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX ), a biopharmaceutical company focused on developing epigenetic ...Durect Corp. analyst ratings, historical stock prices, earnings estimates & actuals. DRRX updated stock price target summary.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...DRRX Stock USD 6.40 0.02 0.31% Durect stock price prediction is an act of determining the future value of Durect shares using few different conventional methods such as EPS estimation , analyst consensus, or fundamental intrinsic valuation .A share price of Durect Corp [DRRX] is currently trading at $2.92, up 12.31%. An important factor to consider is whether the stock is rising or falling in short-term value. The DRRX shares have gain 13.62% over the last week, with a monthly amount glided 3.55%, and seem to be holding up well over a

See the latest Durect Corp stock price (DRRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors can find some trueLast reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin. Durect Corp [DRRX] stock prices are up 4.33% to $0.65 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The DRRX shares have gain 3.03% over the last week, with a monthly amount drifted -73.90%, and not seem to be holding upAlzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43 ...Real time Durect (DRRX) stock price quote, stock graph, news & analysis. The Neurocrine Biosciences 52-week low stock price is 89.04, which is 23.6% below the current share price. ... DURECT (DRRX), United States, $0.019B, 0.00.Durect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ... Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.

Mar-09-21 09:00AM. DURECT Corporation Announces Publication of DUR-928's Mechanism of Action. (PR Newswire) DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic …

Stock Price and Dividend Data for Durect Corp (DRRX), including dividend dates, dividend yield, company news, and key financial metrics.

DRRX is a biopharmaceutical company that develops medicines based on its epigenetic regulator and pharmaceutical programs. The stock price forecast is $34.25, an increase of 1,275.50% from the latest price, according to 4 analysts. The company offers ALZET product line for research in mice, rats, and other laboratory animals.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median...DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...May 17, 2023 · Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ... DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Get the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Durect (DRRX) shares soared 11.8% in the last trading session to close at $6.65. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?The BigBear.ai Holdings stock price fell by -3.70% on the last day (Wednesday, 29th Nov 2023) from $1.89 to $1.82. During the last trading day the stock fluctuated 10.06% from a day low at $1.79 to a day high of $1.97. The price has risen in 6 of the last 10 days but is still down by -3.19% for this period. Volume has increased on the last day ...Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ... Analyst Forecast. According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,883.61% from the latest price.

Get the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.The inventory’s buying and selling value of $2.58 and common value goal of $29.80 mirror the excessive potential of the main drug candidate – and indicate a 1,064% achieve subsequent yr. (be seen DRRX stock forecast)Find the latest DURECT Corporation DRRX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range …Instagram:https://instagram. best dog trainer insurancepflt dividend history401k 2025 contribution limit irshow.much is a gold bar worth Analyst Price Forecast Suggests 670.31% Upside. As of ... The put/call ratio of DRRX is 2.53, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27.10% ... yeti stockswhy is apple down today However, it does not forecast the overall direction of its price. In a nutshell, if Durect's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Durect stock will not fluctuate a lot when Durect's options are near their ...Analyst Price Forecast Suggests 611.06% Upside. As of ... The put/call ratio of DRRX is 2.39, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27.10% ... what is the best medicaid plan in washington state 17 Oct 2022 ... A few shares may have traded at a slightly higher price on a different day with a lower closing price.) ... DRRX, DURECT, -84%, 2/3/2021. 287 ...Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43 ...According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00.